Lipid-lowering agents for nephrotic syndrome-Reference-Cited by-同舟云学术

Lipid-lowering agents for nephrotic syndrome

Published:2013-12-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kong Xiangyu¹,Yuan Hao²,Fan Junming³,Li Zi⁴,Wu Taixiang⁵,Jiang Lanhui⁶

Affiliation:

1. Chengdu Medical College; Department of Epidemiology and Biostatistics, School of Public Health; Chengdu China

2. West China Hospital, Sichuan University; Department of Evidence-Based Medicine and Clinical Epidemiology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041

3. Luzhou Medical College; Department of Nephrology; No. 319 Zhong Shan Road Luzhou Sichuan China

4. West China Hospital, Sichuan University; Department of Nephrology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041

5. West China Hospital, Sichuan University; Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041

6. West China Hospital, Sichuan University; Chinese Evidence-Based Medicine Centre; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005425.pub2/fullpdf

Reference57 articles.

1. The effects of gemfibrozil on hyperlipidaemia in children with persistent nephrotic syndrome;Buyukcelik;Turkish Journal of Pediatrics,2002

2. Gheith O Saad M Sobh M Nephrotic dyslipidaemia, harvest of treatment [abstract] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon (Portugal) 2004 258

3. Study the effect of treatment of nephrotic dyslipidaemia on renal function, fat deposits and scarring in patients with persistent nephrotic syndrome [abstract];Gheith;Nephrology Dialysis Transplantation,2002

4. Impact of treatment of dyslipidaemia on renal function, fat deposits and scarring in patients with persistent nephrotic syndrome;Gheith;Nephron,2002

5. Efficacy and safety of Monascus purpureus Went rice in children and young adults with secondary hyperlipidaemia: A preliminary report;Gheith;European Journal of Internal Medicine,2009

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remission induced by renal protective therapy in nephrotic syndrome with thin basement membrane in an older patient: a case report;Journal of Medical Case Reports;2024-05-03

2. How to Choose the Right Treatment for Membranous Nephropathy;Medicina;2023-11-14

3. Proprotein convertase subtilisin/kexin type 9 targets megalin in the kidney proximal tubule and aggravates proteinuria in nephrotic syndrome;Kidney International;2023-10

4. The Potential Impact of MYH9 (rs3752462) and ELMO1 (rs741301) Genetic Variants on the Risk of Nephrotic Syndrome Incidence;Biochemical Genetics;2023-08-18

5. Inadequate treatment in a patient with minimal change disease (MCD) nephrotic syndrome: a case report;Bali Medical Journal;2023-06-24